Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fujitsu 5 ADR Representing Ord Shs FJTSY

Fujitsu Ltd is a Japan-based company mainly engaged in the information communication technology (ICT) business providing various solutions and development, manufacturing, sales and maintenance of products and electronic devices. The Company operates through three segments. Technology Solutions segment is engaged in the system integration including system construction, business applications, consulting services, and outsourcing services. Ubiquitous Solutions segment is engaged in provision of personal computer services. Device Solutions segment is engaged in the electronic components such as semiconductor packages, batteries.


PINL:FJTSY - Post by User

Post by whytestockson May 08, 2024 11:45pm
82 Views
Post# 36030365

Fujitsu introduces "explainable AI" for use in genomic medic

Fujitsu introduces "explainable AI" for use in genomic medic
JUST IN: $FJTSY Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planningFujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning TOKYO, May 9, 2024 - (JCN Newswire) - Fujitsu today announced the development of explainable AI technology that automatically draws on data in multiple formats, including text, images, and ...FJTSY - Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning

<< Previous
Bullboard Posts
Next >>